Also trades as: BUX.CN (CNQ) · $vol 0M
BMKDF OTC
BioMark Diagnostics Inc.
1W: +6.8%
1M: +7.2%
3M: -6.0%
YTD: +12.5%
1Y: +60.8%
3Y: +81.2%
5Y: +92.9%
$0.39
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
+0.4% ▲
Capital Expenditures
$4K
-19.8% ▼
Free Cash Flow
-$1M
+0.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
-180.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1M | -$2M | -$1M | -$2M | -$1M |
| Depreciation & Amort. | $180K | $386K | $393K | $401K | $382K |
| Stock-Based Comp. | $0 | $330K | $75K | $367K | $45K |
| Change in Working Capital | $43K | $138K | -$86K | $5K | -$95K |
| Other Non-Cash Items | $28K | $74K | $63K | $61K | $56K |
| Operating Cash Flow | -$1M | -$914K | -$983K | -$1M | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | -$59K | -$5K | -$4K | -$4K | -$4K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | -$4M |
| Investment Sales | $0 | $0 | $0 | $0 | $3M |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$59K | -$5K | -$4K | -$4K | -$396K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$161K | -$300K | -$407K | -$413K | -$433K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $929K | $306K | -$63K | $224K | $55K |
| Financing Cash Flow | $768K | $609K | $1M | $3M | -$378K |
| Net Change in Cash | -$495K | -$311K | $85K | $2M | -$2M |
| Cash End of Period | $383K | $72K | $157K | $2M | $619K |
| Free Cash Flow | -$1M | -$920K | -$987K | -$1M | -$1M |